Russell Investments Group
BIOA

Russell Investments Group’s BioAge Labs BIOA Stock Holding History

Russell Investments Group’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.94M Buy
79,196
+15,940
+25% +$288K ﹤0.01% 2115
2026
Q1 		$1.11M Buy
63,256
+21,948
+53% +$423K ﹤0.01% 2166
2025
Q4 		$547K Buy
41,308
+36,779
+812% +$326K ﹤0.01% 2456
2025
Q3 		$26.6K Buy
+4,529
New +$21.2K ﹤0.01% 3512

Other funds holding BIOA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
ACM
Alessandra Capital Management Torrance, California $141M AUM
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $335M AUM 275.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Russell Investments Group's BIOA Position: Q2 2026 in Review

Russell Investments Group increased its BioAge Labs (BIOA) stake by 25% in Q2 2026, buying an estimated $288K and bringing the position to 79,196 shares worth $1.94M. The position accounts for ﹤0.01% of the portfolio, ranked #2115.

Russell Investments Group first reported a position in BIOA in Q3 2025 and has held it in 4 quarters since. 43 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Russell Investments Group held 79,196 shares of BioAge Labs worth $1.94M as of Q2 2026.
  • Russell Investments Group bought 15,940 BioAge Labs shares in Q2 2026, an estimated $288K.
  • BioAge Labs made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #2115 holding.
  • Russell Investments Group first reported a position in BioAge Labs in Q3 2025 and has held it in 4 quarters since.
  • 43 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.